In conclusion, this meta-analysis evaluates the relationship between genetic polymorphisms and CRC risk and reveals that EPHX1 Tyr113His polymorphism may be not associated with CRC development; while the EPHX1 His139Arg polymorphism may have a potential protective effect on CRC. The gene discussed is EPHX1; the disease is colorectal carcinoma.